Accretion Pharmaceuticals Limited (NSE:ACCPL)
India · Delayed Price · Currency is INR 153.60
-0.40 (-0.26%)
At close: Jul 8, 2026
Accretion Pharmaceuticals Market Cap
Accretion Pharmaceuticals has a market cap or net worth of 1.71 billion as of July 8, 2026. Its market cap has increased by 120.63% in one year.
Market Cap
1.71B
Enterprise Value
1.79B
Revenue
898.18M
Ranking
n/a
PE Ratio
17.05
Stock Price
153.60
Market Cap Chart
Since May 21, 2025, Accretion Pharmaceuticals's market cap has increased from 922.07M to 1.71B, an increase of 85.65%. That is a compound annual growth rate of 72.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 1.71B | 74.84% |
| Dec 31, 2025 | 976.54M | 5.91% |
| May 21, 2025 | 922.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ambalal Sarabhai Enterprises | 2.47B |
| Sat Kartar Life | 2.26B |
| Kerala Ayurveda | 2.22B |
| Coral Laboratories | 2.20B |
| Sanjivani Paranteral | 1.87B |
| Bio Medica Laboratories | 1.75B |
| Oxygenta Pharmaceutical | 1.75B |
| Parnax Lab | 1.68B |